Aimco Pesticides Ltd Q2 FY26 – When Your Balance Sheet Looks Like a Pest-Infested Crop Field

1. At a Glance

If you thought pesticides only kill bugs, wait till you see what Aimco Pesticides Ltd has done to shareholder wealth. With a market cap of barely ₹53.5 crore and a current price of ₹54.7 (down from ₹118 just months ago), this agrochemical player is having a brutal year — one that could make even locusts look merciful. The company’s Q2 FY26 numbers (quarter ended September 2025) show sales at ₹45.6 crore, down 17.6% QoQ, and a net loss of ₹4.02 crore — a stunning 279% dive from the previous quarter.

Operating margins? A negative 7.5%. ROE? -22.3%. ROCE? -12.4%. Debt-to-equity? 0.69. Basically, the only thing growing here is the pile of red ink. Over the past six months, the stock has lost 36%, and in a year, a painful 43%.

At this point, Aimco’s financials look like a cotton field after a pesticide overdose — toxic, patchy, and full of regrets. Yet, somehow, this company keeps exporting to 45 countries. Maybe international buyers are less concerned with profitability and more impressed that Aimco once made Chlorpyrifos before anyone else in India.

2. Introduction

Welcome to the world of Aimco Pesticides Ltd — where margins evaporate faster than monsoon puddles and losses multiply like aphids on a sugarcane stalk. Incorporated in 1987, Aimco started out as one of India’s pioneering agrochemical manufacturers, proudly producing Chlorpyrifos and Triclopyr before most Indian companies had even figured out what a molecule patent was.

But fast-forward to FY25, and the story reads more like “Lagaan” — except here, the farmers aren’t paying taxes, they’re watching the company’s EPS turn negative every quarter. With exports making up nearly 58% of revenue and domestic sales contributing 42%, Aimco has a truly global footprint. Unfortunately, even its global reach couldn’t prevent it from tripping over supply chain costs, China dependency, and weak domestic demand.

The company’s revenue for FY25 stood at around ₹198 crore, but profits fell deep into the negative territory with a loss of ₹10.2 crore. Despite this, the management continues to promise “portfolio expansion” and “innovation,” like a student who keeps assuring parents he’ll pass next semester — after failing all subjects again.

So, what went wrong? Or rather, what hasn’t gone right for this pesticide veteran? Let’s dig into the business, numbers, and drama that make Aimco Pesticides one of the more “chemically volatile” small caps on the market.

3. Business Model – WTF Do They Even Do?

Aimco Pesticides manufactures, markets, and exports technical-grade chemicals and formulations used in insecticides, fungicides, and herbicides. The company runs its operations through four key segments:

1. Technical Chemicals (59% of FY24 revenue) – Bulk sales to other formulators, both domestic and international. Think of this as Aimco’s B2B backbone.
2. Branded Formulations (32%) – Retail-focused, B2C sales via distributors under Aimco’s own brands.
3. B2B Formulations (15%) – Bulk packaging exports to regions like Brazil, Africa, and the Gulf.
4. Trading (1%) – A tiny segment focused on opportunistic global sales, mostly to Australia and the USA.

Their product lineup includes 90+ formulations — emulsifiable concentrates, suspension concentrates, and water-dispersible granules — all designed to protect crops from pests. The company also operates a 23,000 sq. meter integrated facility in Ratnagiri, Maharashtra, producing 6,000 tonnes of technical chemicals and 7,000 tonnes each of liquid and granule formulations annually.

Sounds impressive, right? Except the financials look like the crop after a pest attack — every leaf eaten, nothing left to show. Aimco’s overdependence on Chinese raw materials hasn’t helped, nor has its poor working capital management (current ratio 0.88).

Still, you have to respect the hustle — surviving in the agrochemical industry with negative returns requires the persistence of a weed.

4. Financials Overview

Let’s dissect Q2 FY26 — the “Half Yearly Results” period where Aimco’s balance sheet screamed louder than a farmer spotting locusts.

Aimco’s numbers tell a tragicomic story. The sales have declined YoY and QoQ, operating profits